Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate
Open Access
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 6 (1) , 119-126
- https://doi.org/10.1006/mthe.2002.0639
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genistein Restores Functional Interactions between ΔF508-CFTR and ENaC in Xenopus OocytesJournal of Biological Chemistry, 2002
- In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.Journal of Clinical Investigation, 1997
- Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosisEuropean Respiratory Journal, 1997
- In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic FibrosisHuman Gene Therapy, 1995
- Butyrate in the treatment of sickle cell disease and β-thalassemiaCurrent Opinion in Hematology, 1995
- Butyrate and phenylacetate as differentiating agents: Practical problems and opportunitiesJournal of Cellular Biochemistry, 1995
- Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C → T mutationThe Lancet, 1993
- Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitiveNature, 1992
- Mislocalization of ΔF508 CFTR in cystic fibrosis sweat glandNature Genetics, 1992
- Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In Xenopus OocytesScience, 1991